about
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesProtective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.Osteoporosis, inflammation and ageingT cell replicative senescence in human agingThe anti-inflammatory role of vitamin e in prevention of osteoporosis.Mesenchymal stromal cells. Nurse-like cells reside in the synovial tissue and bone marrow in rheumatoid arthritis.Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA? A pilot study.RANK, RANKL and osteoprotegerin in arthritic bone loss.Nigella sativa: A Potential Antiosteoporotic AgentPathophysiology of Hemophilic Arthropathy.The IL-10 and IFN-gamma pathways are essential to the potent immunosuppressive activity of cultured CD8+ NKT-like cellsModulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis.Effect of breastfeeding on serum osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in full term neonates.Implications of exercise-induced adipo-myokines in bone metabolism.The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.IL-1beta suppresses the formation of osteoclasts by increasing OPG production via an autocrine mechanism involving celecoxib-related prostaglandins in chondrocytes.Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.The impact of chronic inflammation on bone turnover in hemodialysis patients.
P2860
Q24683018-FACDBED3-0D3A-423B-836C-5E6789361306Q24812326-0DD359A0-F119-4799-B682-65F74973188BQ24815520-C57D5B75-6539-4158-89D2-CD3B48B8F114Q27022690-58711AD0-9BBA-4103-9175-B86D1C59FC8EQ35580008-B4348307-832E-470F-BC90-BC481D0C971CQ35769037-DB434CC8-2AC2-4CE2-9C9B-A68FA0DACC3AQ35818302-E6C8C849-0B3D-40F3-9238-E1DC0463ADC3Q36013306-6F6DA308-FEB0-4B13-B344-618ECC63DEF3Q36078073-E262FAA5-18A6-43DE-9110-B2B7E3E5E8DFQ36225602-77129F32-436C-4753-B011-4D12C805C430Q36414215-5B91478E-B0CF-47B6-B19D-BC4349735025Q36864798-C820570B-8FDD-4A5E-BE8D-D512658C4A56Q37596614-F116C51E-20BC-4F31-8C2D-756F2EFEEDEDQ37631987-08CA96E2-2326-4F0F-8409-70B410FF5CDEQ38683297-E76280B4-8737-4269-A76F-266A84214430Q38831693-6B6CD3FA-CEC9-4132-9E25-54342E51E5E6Q39315218-311050F9-DB39-4899-A706-95F43FE01701Q39335782-76B93B2A-8389-48A7-8FDE-513C1A281FA0Q47677138-2E59D0E4-44F5-4FE3-B0B5-FA0E6FAD9DAB
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Role for osteoprotegerin in rheumatoid inflammation.
@ast
Role for osteoprotegerin in rheumatoid inflammation.
@en
type
label
Role for osteoprotegerin in rheumatoid inflammation.
@ast
Role for osteoprotegerin in rheumatoid inflammation.
@en
prefLabel
Role for osteoprotegerin in rheumatoid inflammation.
@ast
Role for osteoprotegerin in rheumatoid inflammation.
@en
P2093
P1433
P1476
Role for osteoprotegerin in rheumatoid inflammation.
@en
P2093
Marie-Christine De Vernejoul
Marie-Christophe Boissier
Martine Cohen-Solal
Natacha Bessis
Nathalie Saidenberg-Kermanac'h
P356
10.1016/S1297-319X(03)00131-3
P577
2004-01-01T00:00:00Z